BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19382092)

  • 1. [Blood-borne infections in hemodialysis: facts and opinions].
    Perboni G; Costa P; Scalzini A
    G Ital Nefrol; 2009; 26 Suppl 45():S32-6. PubMed ID: 19382092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology and prevention in dialysis].
    Cherubini C; Barbera G; Petrosillo N; Di Giulio S
    G Ital Nefrol; 2003; 20 Suppl 22():S38-42. PubMed ID: 12851920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance and control of blood-borne virus infections in haemodialysis units.
    Zuckerman M
    J Hosp Infect; 2002 Jan; 50(1):1-5. PubMed ID: 11825044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 1990s perspective of hepatitis C, human immunodeficiency virus, and tuberculosis infections in dialysis patients.
    Murthy BV; Pereira BJ
    Semin Nephrol; 1997 Jul; 17(4):346-63. PubMed ID: 9241719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupational blood-borne diseases in surgery.
    Fry DE
    Am J Surg; 2005 Aug; 190(2):249-54. PubMed ID: 16023440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines for managing HBV, HCV, and HIV infections in obstetrics].
    Aspöck C; Bettelheim D; Hofmann H; Pollak A; Koller W
    Wien Klin Wochenschr; 1995; 107(20):595-7. PubMed ID: 7502506
    [No Abstract]   [Full Text] [Related]  

  • 8. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
    Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
    Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic viral hepatitis in hemodialysis patients.
    Tang S; Lai KN
    Hemodial Int; 2005 Apr; 9(2):169-79. PubMed ID: 16191066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis and HIV infection during haemodialysis.
    Saha D; Agarwal SK
    J Indian Med Assoc; 2001 Apr; 99(4):194-9, 203, 213. PubMed ID: 11666025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B and C in dialysis units in Iran: changing the epidemiology.
    Alavian SM; Bagheri-Lankarani K; Mahdavi-Mazdeh M; Nourozi S
    Hemodial Int; 2008 Jul; 12(3):378-82. PubMed ID: 18638096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing the transmission of bloodborne pathogens in health care and public service settings.
    Can Commun Dis Rep; 1997 May; 23 Suppl 3():i-vii, 1-43, i-vii, 1-52. PubMed ID: 11195251
    [No Abstract]   [Full Text] [Related]  

  • 16. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia.
    Almawi WY; Qadi AA; Tamim H; Ameen G; Bu-Ali A; Arrayid S; Abou Jaoude MM
    Transplant Proc; 2004; 36(6):1824-6. PubMed ID: 15350487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expanded serologic infection testing of autologous blood donors: a report of experiences].
    Zimmermann R; Weisbach V; Wittmann G; Zingsem J; Neidhardt B; Eckstein R
    Beitr Infusionsther Transfusionsmed; 1996; 33():196-200. PubMed ID: 8974693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of infection in health care workers following occupational exposure to a noninfectious or unknown source.
    Kuruuzum Z; Yapar N; Avkan-Oguz V; Aslan H; Ozbek OA; Cakir N; Yuce A
    Am J Infect Control; 2008 Dec; 36(10):e27-31. PubMed ID: 19084160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data.
    Kliem V; Burg M; Haller H; Suwelack B; Abendroth D; Fritsche L; Fornara P; Pietruck F; Frei U; Donauer J; Lison AE; Michel U
    Transplant Proc; 2008 May; 40(4):909-14. PubMed ID: 18555076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National surveillance of dialysis-associated diseases in the United States, 2002.
    Finelli L; Miller JT; Tokars JI; Alter MJ; Arduino MJ
    Semin Dial; 2005; 18(1):52-61. PubMed ID: 15663766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.